Locations:
SearchAdvertisement
VADs remain underutilized in non-dilated cardiomyopathy patients
Authors from the Cleveland Clinic-led study discuss the findings
Study highlights the utility of an easily calculated score, the MELD-XI, to predict post-transplant outcomes
Further studies evaluating the use of pulmonary vasodilators in patients with more severe illness are needed
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Involving a pediatric cardio-oncologist early in the treatment of pediatric malignancies
Advertisement
Advertisement